Stem cell transplant with special cell depletion for children and young adults
Part of Blood & lymphatic, Cancer clinical trials.
This trial tests a type of stem cell transplant that removes certain immune cells (alpha-beta T cells and CD19 B cells) from the donor cells. This may help prevent graft-versus-host disease and other complications in patients with blood cancers who do not have a matched sibling donor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 30 years or younger.
- You have a blood cancer that can be treated with a stem cell transplant, and you do not have a fully matched brother or sister to donate.
- You are generally well enough to undergo the transplant, with a performance score of 60% or higher.
- Your organs (like heart, lungs, kidneys, liver) are working well enough for the transplant.
- You are not pregnant or breastfeeding, and if you could become pregnant, you have a negative pregnancy test.
- You do not have HIV or an uncontrolled infection (like a serious fungal, bacterial, or viral infection).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special stem cell transplant from a half-matched family donor, designed to reduce rejection and infection risk. It may include a targeted drug (blinatumomab) to help kill remaining cancer cells.
This Phase 2 study tests a specialized stem cell transplant that removes certain immune “T-cell” receptors to help treat blood cancers like acute leukemia. It may help your body rebuild a healthier immune system after high-dose treatment.
This trial offers a special type of stem cell transplant for children and young adults. It uses a machine to remove certain immune cells (alpha/beta T cells and CD19+ cells) from the donated stem cells, which may lower the risk of graft-versus-host disease. The study includes patients who need a first transplant, a second transplant, or a stem cell boost.
This trial studies a special donor stem cell transplant where the donor’s immune cells are reduced, aiming to lower harmful immune attacks after transplant. It may help children and young adults with certain high-risk blood cancers or rare bone marrow disorders.
This Phase 1 trial studies a type of stem cell transplant that removes certain immune cells (called T-cells) to help treat serious blood and immune diseases in children and young adults. It’s meant for patients who need a transplant but may not have an identical donor available in time.
This expanded-access study offers a specific type of stem cell transplant preparation that removes certain immune cells (CD3 and CD19) from donor stem cells. It is for children who need a transplant but do not have a fully matched sibling donor and whose team cannot use the hospital’s usual matching device protocol.
Hear when a new Hematopoietic Stem Cell Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.